Navigation Links
Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder
Date:6/30/2009

FRAZER, Pa., June 30 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) today announced that it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) requesting approval of NUVIGIL(R) (armodafinil) Tablets [C-IV] for the indication of improved wakefulness in patients with excessive sleepiness associated with jet lag disorder resulting from eastbound travel. Jet lag disorder is an acute condition that occurs when a person's internal body clock becomes disrupted as a result of rapid travel across several time zones. Based on U.S. Bureau of Labor Statistics findings, an estimated 70 million American travelers experience jet lag annually. Currently, there are no FDA-approved medications to improve wakefulness in travelers who experience the excessive sleepiness commonly associated with long flights.

"This supplemental New Drug Application for a new use of NUVIGIL is another important milestone for Cephalon. We hope that this will be the first of many new indications for NUVIGIL over the next five years," said Dr. Lesley Russell, Chief Medical Officer and Executive Vice President at Cephalon.

The NUVIGIL sNDA for the treatment of excessive sleepiness associated with jet lag disorder is based on data from a Phase 3 study, recently presented at the SLEEP 2009 23rd Annual Meeting of the Associated Professional Sleep Societies in Seattle, Washington. The data from this novel placebo-controlled pivotal study, which involved overseas air travel, included an evaluation of the efficacy and safety of NUVIGIL (50 or 150 mg/day) in 427 healthy men and women who all had experienced jet lag symptoms at least once during the previous five years. Clinical efficacy was evaluated using two primary endpoints: an objective assessment -- the Multiple Sleep Latency Test (MSLT), and a subjective a
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
2. Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder
3. Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression
4. Cephalon Signs Option Agreement to Acquire Ception Therapeutics
5. Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain
6. Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkins Lymphoma
7. Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non-Hodgkins Lymphoma
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. PharmAthene Submits Proposal to BARDA in Response to Broad Agency Announcement for Advanced Research and Development for Valortim(R)
10. PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA
11. Human Genome Sciences Submits Biologics License Application to FDA for ABthrax(TM)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...,, NORTHHOLLYWOOD,Calif.,Nov.24/PRNewswire-Fi...CM ),aleadingnationalhospitalistphysiciangroupprac...ACP,anIPChospitalist,wasnamedby ACPHospitalist aso...gnizedintheNovember2009issueofthemagazine. ,, D...earsandcurrentlyservesasdirectorofhospitalmedicine...
(Date:11/24/2009)...,, MOUNTAINVIEW,Calif.,Nov.24/PRNewswire/--Sa...rovidersofkidneydialysisservicesandamajorsponsorof...enalDiseasesurvivorandchefEliasNasrallahinhiseffor...y. ,, EliasNasrallahbuiltasuccessfulcareerasach...ide-downfiveyearsago,whenhewasdiagnosedwithEndStag...
(Date:11/24/2009)...,, SANDIEGO,Nov.24/PRNewswire-FirstCall/--Opt...topresentatthe21stAnnualPiperJaffrayHealthCareConf...009at1:00p.m.EasternTime. ,, (Logo: http://www...., Aliveaudiowebcastofthispresentationwillbeacces...w.optimerpharma.com .Replaysofthispresentationwil...
Breaking Medicine Technology:IPC The Hospitalist Company's Philip Vaidyan, M.D. Named a Top Hospitalist of 2009 2Satellite Healthcare and Renal Disease Survivor Elias Nasrallah Join Forces to Support the Homeless This Holiday Season 2Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery 5145 1Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery 5145 2Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery 5145 3Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery 5145 4Allen Medical Systems Announces Surgeon Spotlight Series Interview 5143 1Allen Medical Systems Announces Surgeon Spotlight Series Interview 5143 2Allen Medical Systems Announces Surgeon Spotlight Series Interview 5143 3Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion 5141 1Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion 5141 2Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion 5141 3
...ems Incorporated,(Nasdaq: IMCL ) and Bristol-Myer...t the U.S. Food and Drug Administration (FDA) has ...roduct labeling to include overall survival,data a...tor,(EGFR)-expressing metastatic colorectal cancer... and oxaliplatin-based regimens. The approval of ...
...tudies have suggested that,moderate red wine consu...,what if you,d like to skip the alcohol? Take hear...EALTH 2007 conference in Bordeaux, France,showed t...axation effect in,a similar fashion to red wine. T...rd grape juice induced a prolonged relaxation effe...
Other Medicine Technology:Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 2Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 3Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 4Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 5Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 6Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 7New Study Shows Concord Grape Juice has a Heart-Healthy Effect not yet Reported With Red Wine 2
(Date:11/25/2009)...aremanywaysyoucanimprove,yourhealth,andjustafewsma...econflictingadviceconcerningwhatisgoodforus,andthe...z.comteamhascompiledalistof25health-boostingtips,w...combinationof,oursuggestedactivitieswillboostyourh...emout. , 1.Reduceyourfatintake.Theeffectsoffa...
(Date:11/24/2009)...ide accurate preliminary interpretation of emergen...ing neuroradiologist unavailable, according to res...a center published in the December issue of the J...R ). , The accuracy of image interpretation is .... In most training programs, radiology residents p...
(Date:11/24/2009)...ewswire/--EnigmaDiagnosticsLimited,thedecentralise...ncedtodayfourseniorappointmentsforitsUSandEuropean...esidentandCEOwithGregHamilton,ChiefOperatingOffice...ewU.S.headquartersinSanDiego,California,theheadqua...nnedforassaydevelopment,R&Dandcommercialactivi...
(Date:11/24/2009)...SNewswire/--Parties,familydinners,andothergatherin...themerrimentcanchangetomiseryiffoodmakesyouorother...prnh/20090824/FDALOGO ) ,, Typicalsymptomsoffoo...oms,whichcanstartanywherefromhourstodaysafterconta...isthatpracticingfourbasicfoodsafetymeasurescanhelp...
(Date:11/24/2009)...thPlusofMichiganhaslaunchedfournew HealthPlusSigna...als18to64andtheirfamilieswhoarelookingtopurchaseaf...hPlusSignature plansareavailableonlineat www.Healt...HealthPlusservicearea.Moreinformation,includinghel...lto1-877-562-0907. ,, "Wearepleasedtoofferanarr...
Breaking Medicine News(10 mins):Health News:realbuzz.com - Top 25 Ways to Improve Your Health & get a Better Sex Life! 2Health News:Enigma Diagnostics Expands Its US and European Executive Management Teams 2Health News:Enigma Diagnostics Expands Its US and European Executive Management Teams 3Health News:FDA Consumer Health Information: Food Safety Tips for Healthy Holidays 2Health News:HealthPlus Offers New Insurance Plans for Consumers Seeking Health Coverage on Their Own 2
...p those fighting colon, lung or pancreatic maligna...ws) -- What if a blood test or biopsy could predic...make you feel worse? , Tests like these, based on... news conference Tuesday. , "The ultimate goal is ...
...l Trials on Schedule, HAIKOU CITY, China, Oct. 29...dings, Inc. ("China Pharma") (OTC Bulletin Board: ...eneric and branded bio-pharmaceutical,products in ... enter clinical trials., The Company will initiat...
...ay window -, PITTSBURGH, Oct. 29 Mylan Inc. (NYS... Limited, its India-based,subsidiary in which it h...Pfizer Inc.,s patents for its Vfend(R) Tablets, 50...riod provided by the,Hatch-Waxman Act to initiate ...
...onsumer-Driven Products, According to...LLE, Tenn., Oct. 29 HealthLeaders-InterStudy, a,l...e, reports that despite,its trend-setter reputatio...r their products. According to the,latest Californ...
...EPS $0.62; Adjusted EPS $0.47, CORONA, Calif., Oc... a leading specialty pharmaceutical,company, today...ended,September 30, 2008., Third Quarter 2008 Res...71.1 million, or $0.62 per diluted share. Excludin...
...esamorelin, a Phase III compound being invest...n HIV patients with lipodystrophy -- Therat...ncreasing -- royalties on net sales in the US -...ption to participate in future tesamorelin -- in...
Other Medicine News:Health News:Tests Could Predict Benefit From Cancer Drugs 2Health News:Tests Could Predict Benefit From Cancer Drugs 3Health News:China Pharma Holdings, Inc. to Initiate Clinical Trials For New Antibiotic Combination 2Health News:China Pharma Holdings, Inc. to Initiate Clinical Trials For New Antibiotic Combination 3Health News:Mylan's Matrix First-to-File on Generic Version of Vfend(R) Antifungal 2Health News:California Insurers are Behind the Curve with Consumer-Driven Health Plans 2Health News:Watson Pharmaceuticals Reports Third Quarter 2008 Results 2Health News:Watson Pharmaceuticals Reports Third Quarter 2008 Results 3Health News:Watson Pharmaceuticals Reports Third Quarter 2008 Results 4Health News:Watson Pharmaceuticals Reports Third Quarter 2008 Results 5Health News:Watson Pharmaceuticals Reports Third Quarter 2008 Results 6Health News:Watson Pharmaceuticals Reports Third Quarter 2008 Results 7Health News:Watson Pharmaceuticals Reports Third Quarter 2008 Results 8Health News:Watson Pharmaceuticals Reports Third Quarter 2008 Results 9Health News:Watson Pharmaceuticals Reports Third Quarter 2008 Results 10Health News:Watson Pharmaceuticals Reports Third Quarter 2008 Results 11Health News:Watson Pharmaceuticals Reports Third Quarter 2008 Results 12Health News:Watson Pharmaceuticals Reports Third Quarter 2008 Results 13Health News:Watson Pharmaceuticals Reports Third Quarter 2008 Results 14Health News:Watson Pharmaceuticals Reports Third Quarter 2008 Results 15Health News:Watson Pharmaceuticals Reports Third Quarter 2008 Results 16Health News:Watson Pharmaceuticals Reports Third Quarter 2008 Results 17Health News:EMD Serono and Theratechnologies Announce Collaboration and Licensing Agreement for Tesamorelin in the United States 2Health News:EMD Serono and Theratechnologies Announce Collaboration and Licensing Agreement for Tesamorelin in the United States 3Health News:EMD Serono and Theratechnologies Announce Collaboration and Licensing Agreement for Tesamorelin in the United States 4Health News:EMD Serono and Theratechnologies Announce Collaboration and Licensing Agreement for Tesamorelin in the United States 5
Cloward Dowel
Connect Cervical Allografts System
Lorenz 2.0 mm Mini-plate Titanium
... maxillo-facial and cranial surgery are characteri...he most varied of applications. Tailor-made instru...the system is easy to implement and saves time. Th...ned instruments for drilling, screwing, bending an...
Medicine Products: